Search for tag: "dopamine"

5 Media

01:05:26 CP2 CNS2 Parkinson's disease Dr Phil Larkman CP2 CNS2 Parkinson's disease Dr Phil Larkman	CP2 CNS2 Parkinson's disease Dr Phil Larkman Pharmacology of Parkinson's disease l-dopa dopamine disease dopa neurons pathway brain parkinson ganglia basal motor symptoms output treatment receptors nuclei degeneration drug drugs phosphorylation pathophysiology From Philip Larkman on March 2nd, 2021 0 likes 20 plays 0 Licence Type Creative Commons - Attribution
11:59 Pharmacology 3: Parkinson's Disease - Part 4… Pharmacology 3: Parkinson's Disease - Part 4 Dr Phil Larkman	Pharmacology 3: Parkinson's Disease - Part 4 Dr Phil Larkman Causes disease neurons parkinson phosphorylation aggregates cells stress dopamine pathophysiology cases death processes symptoms factors protein brain mptp cell levels degeneration From Philip Larkman on November 15th, 2020 0 likes 79 plays 0 Licence Type Creative Commons - Attribution
08:29 Pharmacology 3: Parkinson's Disease - Part 2… Pharmacology 3: Parkinson's Disease - Part 2 Dr Phil Larkman	Pharmacology 3: Parkinson's Disease - Part 2 Dr Phil Larkman Pathophysiology - the function of the basal ganglia output pathway ganglia basal neurons motor inhibitory nuclei dopamine inhibition receptors nucleus globus capsule striatum cortex pathways thalamus signals excitatory From Philip Larkman on November 15th, 2020 0 likes 91 plays 0 Licence Type Creative Commons - Attribution
09:31 Pharmacology 3: Parkinson's Disease - Part 1… Pharmacology 3: Parkinson's Disease - Part 1 Dr Phil Larkman	Pharmacology 3: Parkinson's Disease - Part 1 Dr Phil Larkman Symptoms and pathophysiology motor neurons disease symptoms patient dopamine ganglia basal signals regions patients parkinson thalamus control degeneration disorder pathway nigra substantia nucleus From Philip Larkman on November 15th, 2020 0 likes 85 plays 0 Licence Type Creative Commons - Attribution
12:18 Pharmacology 3: Parkinson's Disease - Part 3… Pharmacology 3: Parkinson's Disease - Part 3 Dr Phil Larkman	Pharmacology 3: Parkinson's Disease - Part 3 Dr Phil Larkman Drug treatment dopa dopamine treatment brain disease parkinson levels patient effect drug decarboxylase drugs oxidase conversion ganglia basal methyltransferase monoamine symptoms receptors From Philip Larkman on November 15th, 2020 0 likes 83 plays 0 Licence Type Creative Commons - Attribution

the university of edinburgh

The University of Edinburgh is a charitable body, registered in Scotland, with registration number SC005336, VAT Registration Number GB 592 9507 00, and is acknowledged by the UK authorities as a “Recognised body” which has been granted degree awarding powers.

Any views expressed within media held on this service are those of the contributors, should not be taken as approved or endorsed by the University, and do not necessarily reflect the views of the University in respect of any particular issue.

Search for tag: "dopamine"

CP2 CNS2 Parkinson's disease Dr Phil Larkman

Pharmacology 3: Parkinson's Disease - Part 4 Dr Phil Larkman

Pharmacology 3: Parkinson's Disease - Part 2 Dr Phil Larkman

Pharmacology 3: Parkinson's Disease - Part 1 Dr Phil Larkman

Pharmacology 3: Parkinson's Disease - Part 3 Dr Phil Larkman

the university of edinburgh